Markel Group
MKL
#933
Rank
$26.59 B
Marketcap
$2,102
Share price
0.34%
Change (1 day)
3.74%
Change (1 year)
Markel Corporation is a holding company for insurance, reinsurance, and investment operations around the world.

Markel Group - 10-Q quarterly report FY


Text size:
Table of Contents

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

 


 

FORM 10-Q

 


 

x Quarterly report pursuant to section 13 or 15(d) of the Securities Exchange Act of 1934

for the quarterly period ended June 30, 2003

 

or

 

¨ Transition report pursuant to section 13 or 15(d) of the Securities Exchange Act of 1934

for the transition period from             to             

 

Commission File Number 001-15811

 


 

MARKEL CORPORATION

(Exact name of registrant as specified in its charter)

 


 

Virginia 54-1959284

(State or other jurisdiction of

incorporation or organization)

 

(I.R.S. employer

identification number)

 

4521 Highwoods Parkway, Glen Allen, Virginia 23060-6148

(Address of principal executive offices)

(Zip code)

 

(804) 747-0136

(Registrant’s telephone number, including area code)

 


 

NONE

(Former name, former address and former fiscal year,

if changed since last report)

 


 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes   x    No  ¨

 

Indicate by check mark whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Exchange Act).    Yes  x    No  ¨

 

Number of shares of the registrant’s common stock outstanding at August 1, 2003: 9,845,727

 



Table of Contents

Markel Corporation

Form 10-Q

 

Index

 

  Page Number

PART I. FINANCIAL INFORMATION

  

Item 1. Financial Statements

  

Consolidated Balance Sheets— June 30, 2003 and December 31, 2002

 3

Consolidated Statements of Operations and Comprehensive Income— Quarters and Six Months Ended June 30, 2003 and 2002

 4

Consolidated Statements of Changes in Shareholders’ Equity— Six Months Ended June 30, 2003 and 2002

 5

Consolidated Statements of Cash Flows— Six Months Ended June 30, 2003 and 2002

 6

Notes to Consolidated Financial Statements— June 30, 2003

 7

Item 2.Management’s Discussion and Analysis of Financial Condition and Results of Operations

 15

Critical Accounting Policies

 15

Item 3.Quantitative and Qualitative Disclosures About Market Risk

 23

Item 4.Controls and Procedures

 24

Safe Harbor and Cautionary Statement

 25

PART II. OTHER INFORMATION

  

Item 4.Submission of Matters to a Vote of Security Holders

 25

Item 6.Exhibits and Reports on Form 8-K

 26

Signatures

 27

Exhibit Index

 28

 

2


Table of Contents

PART I. FINANCIAL INFORMATION

 

Item 1. Financial Statements

 

MARKEL CORPORATION AND SUBSIDIARIES

 

Consolidated Balance Sheets

 

   

June 30,

2003


  

December 31,

2002


 
   (dollars in thousands) 

ASSETS

         

Investments, available-for-sale, at estimated fair value

         

Fixed maturities (cost of $3,486,608 in 2003 and $3,119,814 in 2002)

  $3,638,516  $3,251,186 

Equity securities (cost of $501,120 in 2003 and $406,635 in 2002)

   729,238   550,909 

Short-term investments (estimated fair value approximates cost)

   103,555   67,821 
   


 


Total Investments, Available-For-Sale

   4,471,309   3,869,916 
   


 


Cash and cash equivalents

   349,307   444,236 

Receivables

   465,218   408,542 

Reinsurance recoverable on unpaid losses

   1,502,941   1,586,128 

Reinsurance recoverable on paid losses

   134,779   144,751 

Deferred policy acquisition costs

   176,907   150,547 

Prepaid reinsurance premiums

   227,739   219,665 

Intangible assets

   357,317   361,444 

Other assets

   191,096   223,331 
   


 


Total Assets

  $7,876,613  $7,408,560 
   


 


LIABILITIES AND SHAREHOLDERS’ EQUITY

         

Unpaid losses and loss adjustment expenses

  $4,467,216  $4,366,803 

Unearned premiums

   1,029,834   937,364 

Payables to insurance companies

   135,217   122,191 

Convertible notes payable (estimated fair value of $99,000 in 2003 and $89,000 in 2002)

   88,333   86,109 

Long-term debt (estimated fair value of $531,000 in 2003 and $415,000 in 2002)

   477,571   404,384 

Other liabilities

   199,187   182,598 

Company-Obligated Mandatorily Redeemable Preferred Capital Securities of Subsidiary Trust Holding Solely Junior Subordinated Deferrable Interest Debentures of Markel Corporation (estimated fair value of $143,000 in 2003 and $118,000 in 2002)

   150,000   150,000 
   


 


Total Liabilities

   6,547,358   6,249,449 
   


 


Shareholders’ equity

         

Common stock

   736,531   736,246 

Retained earnings

   346,855   251,568 

Accumulated other comprehensive income

         

Net unrealized holding gains on fixed maturities and equity securities, net of tax expense of $133,009 in 2003 and $96,476 in 2002

   247,017   179,170 

Cumulative translation adjustments, net of tax benefit of $618 in 2003 and $4,239 in 2002

   (1,148)  (7,873)
   


 


Total Shareholders’ Equity

   1,329,255   1,159,111 

Commitments and contingencies

         
   


 


Total Liabilities and Shareholders’ Equity

  $7,876,613  $7,408,560 
   


 


 

See accompanying notes to consolidated financial statements.

 

3


Table of Contents

MARKEL CORPORATION AND SUBSIDIARIES

 

Consolidated Statements of Operations and Comprehensive Income

 

   Quarter Ended
June 30,


  Six Months Ended
June 30,


 
   2003

  2002

  2003

  2002

 
   (dollars in thousands, except per share data) 

OPERATING REVENUES

                 

Earned premiums

  $438,873  $346,276  $871,226  $673,815 

Net investment income

   45,467   42,576   90,700   84,040 

Net realized gains from investment sales

   36,732   11,471   43,203   17,095 
   


 


 


 


Total Operating Revenues

   521,072   400,323   1,005,129   774,950 
   


 


 


 


OPERATING EXPENSES

                 

Losses and loss adjustment expenses

   279,933   239,268   559,952   473,724 

Underwriting, acquisition and insurance expenses

   138,157   111,669   273,793   212,918 

Amortization of intangible assets

   1,498   2,629   4,127   5,426 
   


 


 


 


Total Operating Expenses

   419,588   353,566   837,872   692,068 
   


 


 


 


Operating Income

   101,484   46,757   167,257   82,882 

Interest expense

   13,641   10,872   25,036   19,953 
   


 


 


 


Income Before Income Taxes

   87,843   35,885   142,221   62,929 

Income tax expense

   28,988   12,648   46,933   22,655 
   


 


 


 


Net Income

  $58,855  $23,237  $95,288  $40,274 
   


 


 


 


OTHER COMPREHENSIVE INCOME

                 

Unrealized gains (losses) on securities, net of taxes

                 

Net holding gains arising during the period

  $111,458  $18,090  $95,929  $9,511 

Less reclassification adjustments for gains included in net income

   (23,876)  (7,457)  (28,082)  (11,112)
   


 


 


 


Net unrealized gains (losses)

   87,582   10,633   67,847   (1,601)

Currency translation adjustments, net of taxes

   4,741   3,783   6,725   3,285 
   


 


 


 


Total Other Comprehensive Income

   92,323   14,416   74,572   1,684 
   


 


 


 


Comprehensive Income

  $151,178  $37,653  $169,860  $41,958 
   


 


 


 


NET INCOME PER SHARE

                 

Basic

  $5.98  $2.37  $9.68  $4.10 

Diluted

  $5.97  $2.36  $9.66  $4.09 
   


 


 


 


 

See accompanying notes to consolidated financial statements.

 

4


Table of Contents

MARKEL CORPORATION AND SUBSIDIARIES

 

Consolidated Statements of Changes in Shareholders’ Equity

 

   Six Months Ended
June 30,


 
   2003

  2002

 
   (dollars in thousands) 

Common Stock

         

Balance at beginning of period

  $736,246  $735,569 

Issuance of common stock and other equity transactions

   285   519 
   


 


Balance at end of period

  $736,531  $736,088 
   


 


Retained Earnings

         

Balance at beginning of period

  $251,568  $176,252 

Net income

   95,288   40,274 

Repurchase of common stock

   (1)  (6)
   


 


Balance at end of period

  $346,855  $216,520 
   


 


Accumulated Other Comprehensive Income

         

Unrealized gains

         

Balance at beginning of period

  $179,170  $173,928 

Net unrealized holding gains (losses) arising during the period, net of taxes

   67,847   (1,601)
   


 


Balance at end of period

   247,017   172,327 

Cumulative translation adjustments

         

Balance at beginning of period

   (7,873)  (641)

Translation adjustments, net of taxes

   6,725   3,285 
   


 


Balance at end of period

   (1,148)  2,644 
   


 


Balance at end of period

  $245,869  $174,971 
   


 


Shareholders’ Equity at End of Period

  $1,329,255  $1,127,579 
   


 


 

See accompanying notes to consolidated financial statements.

 

5


Table of Contents

MARKEL CORPORATION AND SUBSIDIARIES

 

Consolidated Statements of Cash Flows

 

   Six Months Ended
June 30,


 
   2003

  2002

 
   (dollars in thousands) 

OPERATING ACTIVITIES

         

Net Income

  $95,288  $40,274 

Adjustments to reconcile net income to net cash provided by operating activities

   163,178   109,689 
   


 


Net Cash Provided By Operating Activities

   258,466   149,963 
   


 


INVESTING ACTIVITIES

         

Proceeds from sales of fixed maturities and equity securities

   2,390,739   974,080 

Proceeds from maturities, calls and prepayments of fixed maturities

   110,188   56,189 

Cost of fixed maturities and equity securities purchased

   (2,889,405)  (988,516)

Net change in short-term investments

   (35,734)  (54,852)

Other

   (1,749)  (5,985)
   


 


Net Cash Used By Investing Activities

   (425,961)  (19,084)
   


 


FINANCING ACTIVITIES

         

Additions to long-term debt

   247,282   165,000 

Repayments and repurchases of long-term debt and convertible notes payable

   (175,000)  (167,833)

Other

   284   138 
   


 


Net Cash Provided (Used) By Financing Activities

   72,566   (2,695)
   


 


Increase (decrease) in cash and cash equivalents

   (94,929)  128,184 

Cash and cash equivalents at beginning of period

   444,236   296,781 
   


 


Cash and Cash Equivalents at End of Period

  $349,307  $424,965 
   


 


 

See accompanying notes to consolidated financial statements.

 

6


Table of Contents

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—June 30, 2003

 

1. Principles of Consolidation

 

The consolidated balance sheet as of June 30, 2003, the related consolidated statements of operations and comprehensive income for the quarters and six months ended June 30, 2003 and 2002, the consolidated statements of changes in shareholders’ equity and the consolidated statements of cash flows for the six months ended June 30, 2003 and 2002, are unaudited. In the opinion of management, all adjustments necessary for fair presentation of such consolidated financial statements have been included. Such adjustments consist only of normal recurring items. Interim results are not necessarily indicative of results of operations for the full year. The consolidated balance sheet as of December 31, 2002, was derived from the Company’s audited annual consolidated financial statements.

 

The consolidated financial statements and notes are presented as permitted by Form 10-Q, and do not contain certain information included in the Company’s annual consolidated financial statements and notes. Readers are urged to review the Company’s 2002 annual report on Form 10-K for a more complete description of the Company’s business and accounting policies.

 

Certain reclassifications of prior year’s amounts have been made to conform with 2003 presentations.

 

2. Net Income per share

 

Net income per share was determined by dividing net income by the applicable shares outstanding (in thousands):

 

   Quarter Ended
June 30,


  Six Months Ended
June 30,


   2003

  2002

  2003

  2002

Net income, as reported (basic and diluted)

  $58,855  $23,237  $95,288  $40,274
   

  

  

  

Average common shares outstanding

   9,840   9,825   9,839   9,819

Dilutive potential common shares

   22   29   22   30
   

  

  

  

Average diluted shares outstanding

   9,862   9,854   9,861   9,849
   

  

  

  

 

3. Reinsurance

 

The table below summarizes the effect of reinsurance on premiums written and earned (dollars in thousands):

 

   Quarter Ended June 30,

 
   2003

  2002

 
   Written

  Earned

  Written

  Earned

 

Direct

  $596,913  $558,719  $500,190  $436,783 

Assumed

   21,942   27,481   23,525   22,521 

Ceded

   (142,984)  (147,327)  (120,543)  (113,028)
   


 


 


 


Net premiums

  $475,871  $438,873  $403,172  $346,276 
   


 


 


 


 

7


Table of Contents

3. Reinsurance (continued)

 

   Six Months Ended June 30,

 
   2003

  2002

 
   Written

  Earned

  Written

  Earned

 

Direct

  $1,168,809  $1,112,000  $957,131  $850,537 

Assumed

   94,782   62,801   85,230   36,778 

Ceded

   (312,757)  (303,575)  (265,073)  (213,500)
   


 


 


 


Net premiums

  $950,834  $871,226  $777,288  $673,815 
   


 


 


 


 

Incurred losses and loss adjustment expenses are net of reinsurance recoverables (ceded incurred losses and loss adjustment expenses) of $54.8 million and $61.5 million, respectively, for the quarters ended June 30, 2003 and 2002 and $100.1 million and $158.9 million, respectively, for the six months ended June 30, 2003 and 2002.

 

4. Company Obligated Mandatorily Redeemable Preferred Securities (8.71% Capital Securities)

 

On January 8, 1997, the Company arranged the sale of $150 million of 8.71% Capital Securities issued under an Amended and Restated Declaration of Trust dated January 13, 1997 (the Declaration) by Markel Capital Trust I (the Trust), a statutory business trust sponsored and wholly-owned by the Company. Proceeds from the sale of the 8.71% Capital Securities were used to purchase $154,640,000 aggregate principal amount of the Company’s 8.71% Junior Subordinated Deferrable Interest Debentures (the Debentures) due January 1, 2046, issued to the Trust under an indenture dated January 13, 1997 (the Indenture). The Debentures are the sole assets of the Trust. The Company has the right to defer interest payments on the Debentures for up to five years. The 8.71% Capital Securities and related Debentures are redeemable by the Company on or after January 1, 2007. Taken together, the Company’s obligations under the Debentures, the Indenture, the Declaration and a guarantee made by the Company provide, in the aggregate, a full, irrevocable and unconditional guarantee of payments of distributions and other amounts due on the 8.71% Capital Securities.

 

5. Convertible Notes Payable

 

During 2001 the Company issued $408.0 million principal amount at maturity, $112.9 million net proceeds, of Liquid Yield Option Notes(LYONs). The LYONs are zero coupon senior notes convertible into the Company’s common shares under certain conditions, with an initial conversion price of $243.53 per common share. The issue price of $283.19 per LYON represented a yield to maturity of 4.25%. The LYONs mature on June 5, 2031. The Company uses the effective yield method to recognize the accretion of discount from the issue price to the face amount of the LYONs at maturity. The accretion of discount is included in interest expense.

 

On June 5, 2004, if the price of the Company’s common stock is at or below specified thresholds based on a measurement period prior to that date, contingent additional principal will accrue on the LYONs at a rate of either 0.50% or 1.00% per year for a period of two years, depending on the price of the Company’s common shares. No contingent additional principal will accrue after June 5, 2006.

 

The Company will pay contingent cash interest to the holders of the LYONs during the six-month period commencing June 5, 2006 and during any six-month period thereafter if the average market price of a LYON for a specified period equals or exceeds 120% of the sum of the issue price, accrued original issue discount and contingent additional principal, if any, for the LYON.

 

8


Table of Contents

5. Convertible Notes Payable (continued)

 

Each LYON will be convertible into 1.1629 shares of common stock upon the occurrence of any of the following events: if the closing price of the Company’s common shares on the New York Stock Exchange exceeds specified levels, if the credit rating of the LYONs is reduced below specified levels, if the Company calls the LYONs for redemption, or if the Company is party to certain mergers or consolidations.

 

LYONs holders have the right to require the Company to repurchase the LYONs on June 5th of 2004, 2006, 2011, 2016, 2021 and 2026 at their accreted value on these dates as follows:

 

June 5, 2004

  $321.27

June 5, 2006

  $349.46

June 5, 2011

  $431.24

June 5, 2016

  $532.16

June 5, 2021

  $656.69

June 5, 2026

  $810.36

 

The Company may choose to pay the purchase price for such repurchases in cash or common shares of the Company. The Company may redeem the LYONs for cash on or after June 5, 2006 at their accreted value.

 

6. Unsecured Senior Notes

 

On February 25, 2003, the Company issued $200 million of 6.8% unsecured senior notes due February 15, 2013. The unsecured senior notes were issued under an existing shelf registration statement. Net proceeds to the Company were $198.0 million and were primarily used to repay $175.0 million outstanding under the Company’s revolving credit facility. On April 10, 2003, the Company issued an additional $50 million of 6.8% unsecured senior notes, due February 15, 2013, with net proceeds of $49.3 million.

 

7. Segment Reporting Disclosures

 

The Company operates in three segments of the specialty insurance market: the Excess and Surplus Lines, Specialty Admitted and London Insurance Market.

 

All investing activities are included in the Investing segment. Discontinued programs and non-strategic insurance subsidiaries are included in Other for purposes of segment reporting.

 

The Company considers many factors, including the nature of the underwriting units’ insurance products, production sources, distribution strategies and regulatory environment in determining how to aggregate operating segments.

 

9


Table of Contents

7. Segment Reporting Disclosures (continued)

 

Segment profit or (loss) for each of the Company’s underwriting segments is measured by underwriting profit or (loss). The property and casualty insurance industry commonly defines underwriting profit or (loss) as earned premiums net of losses and loss adjustment expenses and underwriting, acquisition and insurance expenses. Underwriting profit or (loss) does not replace operating income (loss) or net income (loss) computed in accordance with accounting principles generally accepted in the United States of America (U.S. GAAP) as a measure of profitability. Underwriting profit (loss) provides a basis for management to evaluate the Company’s underwriting performance. Segment profit for the Investing segment is measured by net investment income, net of expenses, and net realized gains or losses.

 

The Company does not allocate assets to the Excess and Surplus Lines, Specialty Admitted and London Insurance Market segments for management reporting purposes. The total investment portfolio, cash and cash equivalents are allocated to the Investing segment. The Company does not allocate capital expenditures for long-lived assets to any of its segments for management reporting purposes.

 

Following is a summary of segment disclosures (dollars in thousands):

 

   Quarter Ended June 30, 2003

   Excess and
Surplus Lines


  Specialty
Admitted


  London
Insurance
Market


   Investing

  Other

   Consolidated

Gross premium volume

  $371,802  $73,700  $165,888   $—    $7,465   $618,855

Net premiums written

   265,780   69,320   137,869    —     2,902    475,871

Earned premiums

  $247,242  $57,416  $129,977   $—    $4,238   $438,873

Losses and loss adjustment expenses

   149,339   34,217   86,842    —     9,535    279,933

Underwriting, acquisition and insurance expenses

   69,037   18,460   45,700    —     4,960    138,157
   

  

  


  

  


  

Underwriting profit (loss)

   28,866   4,739   (2,565)   —     (10,257)   20,783
   

  

  


  

  


  

Net investment income

   —     —     —      45,467   —      45,467

Net realized gains from investment sales

   —     —     —      36,732   —      36,732
   

  

  


  

  


  

Segment profit (loss)

  $28,866  $4,739  $(2,565)  $82,199  $(10,257)  $102,982
   

  

  


  

  


  

Amortization of intangible assets

                         1,498

Interest expense

                         13,641
                         

Income before income taxes

                        $87,843
                         

U.S. GAAP combined ratio*

   88%   92%   102%    —     342%    95%
   

  

  


  

  


  

 

10


Table of Contents

7. Segment Reporting Disclosures (continued)

 

   Quarter Ended June 30, 2002

 
   Excess and
Surplus Lines


  Specialty
Admitted


   London
Insurance
Market


   Investing

  Other

   Consolidated

 

Gross premium volume

  $304,303  $62,086   $156,026   $—    $1,300   $523,715 

Net premiums written

   207,174   57,277    138,147    —     574    403,172 

Earned premiums

  $176,659  $43,606   $119,586   $—    $6,425   $346,276 

Losses and loss adjustment expenses

   114,105   31,764    84,156    —     9,243    239,268 

Underwriting, acquisition and insurance expenses

   50,632   13,984    44,329    —     2,724    111,669 
   

  


  


  

  


  


Underwriting profit (loss)

   11,922   (2,142)   (8,899)   —     (5,542)   (4,661)
   

  


  


  

  


  


Net investment income

   —     —      —      42,576   —      42,576 

Net realized gains from investment sales

   —     —      —      11,471   —      11,471 
   

  


  


  

  


  


Segment profit (loss)

  $11,922  $(2,142)  $(8,899)  $54,047  $(5,542)  $49,386 
   

  


  


  

  


  


Amortization of intangible assets

                          2,629 

Interest expense

                          10,872 
                          


Income before income taxes

                         $35,885 
                          


U.S. GAAP combined ratio*

   93%   105%    107%    —     186%    101% 
   

  


  


  

  


  


 

   Six Months Ended June 30, 2003

   Excess and
Surplus Lines


  Specialty
Admitted


  London
Insurance
Market


   Investing

  Other

   Consolidated

Gross premium volume

  $737,411  $131,438  $365,578   $—    $29,164   $1,263,591

Net premiums written

   521,475   122,787   285,589    —     20,983    950,834

Earned premiums

  $483,916  $112,074  $264,215   $—    $11,021   $871,226

Losses and loss adjustment expenses

   295,560   67,932   175,605    —     20,855    559,952

Underwriting, acquisition and insurance expenses

   131,687   38,414   94,931    —     8,761    273,793
   

  

  


  

  


  

Underwriting profit (loss)

   56,669   5,728   (6,321)   —     (18,595)   37,481
   

  

  


  

  


  

Net investment income

   —     —     —      90,700   —      90,700

Net realized gains from investment sales

   —     —     —      43,203   —      43,203
   

  

  


  

  


  

Segment profit (loss)

  $56,669  $5,728  $(6,321)  $133,903  $(18,595)  $171,384
   

  

  


  

  


  

Amortization of intangible assets

                         4,127

Interest expense

                         25,036
                         

Income before income taxes

                        $142,221
                         

U.S. GAAP combined ratio*

   88%   95%   102%    —     269%    96%
   

  

  


  

  


  

 

11


Table of Contents

7. Segment Reporting Disclosures (continued)

 

   Six Months Ended June 30, 2002

 
   Excess and
Surplus Lines


  Specialty
Admitted


   London
Insurance
Market


   Investing

  Other

   Consolidated

 

Gross premium volume

  $585,245  $108,608   $326,985   $—    $21,523   $1,042,361 

Net premiums written

   397,773   101,205    255,262    —     23,048    777,288 

Earned premiums

  $333,787  $82,767   $242,161   $—    $15,100   $673,815 

Losses and loss adjustment expenses

   222,067   55,650    175,516    —     20,491    473,724 

Underwriting, acquisition and insurance expenses

   92,500   28,908    87,537    —     3,973    212,918 
   

  


  


  

  


  


Underwriting profit (loss)

   19,220   (1,791)   (20,892)   —     (9,364)   (12,827)
   

  


  


  

  


  


Net investment income

   —     —      —      84,040   —      84,040 

Net realized gains from investment sales

   —     —      —      17,095   —      17,095 
   

  


  


  

  


  


Segment profit (loss)

  $19,220  $(1,791)  $(20,892)  $101,135  $(9,364)  $88,308 
   

  


  


  

  


  


Amortization of intangible assets

                          5,426 

Interest expense

                          19,953 
                          


Income before income taxes

                         $62,929 
                          


U.S. GAAP combined ratio*

   94%   102%    109%    —     162%    102% 
   

  


  


  

  


  


* The U.S. GAAP combined ratio measures the relationship of incurred losses, loss adjustment expenses and underwriting, acquisition and insurance expenses to earned premiums.

 

   As of

   June 30,
2003


  December 31,
2002


Segment Assets

        

Investing

  $4,820,616  $4,314,152

Other

   3,055,997   3,094,408
   

  

Total Assets

  $7,876,613  $7,408,560
   

  

 

8. Other Comprehensive Income

 

Other comprehensive income is composed of net holding gains on securities arising during the period less reclassification adjustments for gains included in net income. Other comprehensive income also includes currency translation adjustments. The related tax expense on net holding gains on securities arising during the period was $60.0 million and $51.7 million, respectively, for the quarter and six months ended June 30, 2003 and $9.7 million and $5.1 million, respectively, for the same periods in 2002. The related tax expense on the reclassification adjustments for gains included in net income was $12.9 million and $15.1 million, respectively, for the quarter and six months ended June 30, 2003 and $4.0 million and $6.0 million, respectively, for the same periods in 2002. The related tax expense on the currency translation adjustments was $2.6 million and $3.6 million, respectively, for the quarter and six months ended June 30, 2003 and $2.0 million and $1.8 million, respectively, for the same periods in 2002.

 

12


Table of Contents

9. Derivative Financial Instruments

 

The Company held $5.1 million and $100.8 million, respectively, of corporate bonds with embedded put options as of June 30, 2003 and December 31, 2002. These embedded derivatives are clearly and closely related to the host contracts and therefore are not accounted for separately.

 

10. Goodwill and Other Intangible Assets

 

The Company completed the transitional goodwill impairment test early in 2002 as required by Financial Accounting Standards Board Statement (Statement) No. 142, Goodwill and Other Intangible Assets. Goodwill is also required to be tested annually for impairment under Statement No. 142 and the Company has elected September 30 as its annual review date. The Company determined that there was no indication of goodwill impairment at either testing date in 2002.

 

Acquired Intangible Assets (dollars in thousands):

 

   As of June 30, 2003

   Gross
Carrying Amount


  Accumulated
Amortization


  Net
Carrying Amount


Amortized Intangible Assets

            

Lloyd’s capacity costs

  $31,548  $(31,548) $—  
   

  


 

Unamortized Intangible Assets

            

Goodwill

  $405,548  $(48,231) $357,317
   

  


 

Intangible Assets

  $437,096  $(79,779) $357,317
   

  


 

 

   As of December 31, 2002

   Gross
Carrying Amount


  Accumulated
Amortization


  Net
Carrying Amount


Amortized Intangible Assets

            

Lloyd’s capacity costs

  $31,548  $(27,421) $4,127
   

  


 

Unamortized Intangible Assets

            

Goodwill

  $405,548  $(48,231) $357,317
   

  


 

Intangible Assets

  $437,096  $(75,652) $361,444
   

  


 

 

The amortization expense for intangible assets was $1.5 million and $4.1 million, respectively, for the second quarter and six months ended June 30, 2003 and $2.6 million and $5.4 million, respectively, for the same periods in 2002. Amortizable intangible assets were fully amortized at June 30, 2003.

 

13


Table of Contents

10. Goodwill and Other Intangible Assets (continued)

 

There were no changes in the carrying amounts of goodwill for the second quarter and six month period ended June 30, 2003. The following table shows the carrying amounts of goodwill by reporting unit at June 30, 2003 (dollars in thousands):

 

   Excess and
Surplus Lines


  London Insurance
Market


  Total

Balance as of June 30, 2003

  $81,770  $275,547  $357,317
   

  

  

 

11. Contingencies

 

On January 31, 2001, the Company received notice of a lawsuit filed in the United States District Court of the Southern District of New York against Terra Nova Insurance Company Limited by Palladium Insurance Limited and Bank of America, N.A. seeking approximately $27 million plus exemplary damages in connection with alleged reinsurance agreements. This matter is still in the discovery phase and is not expected to be ready for trial before 2004. The Company believes it has numerous defenses to these claims, including the defense that the alleged reinsurance agreements and insurance policies were not valid. The Company intends to vigorously defend this matter; however, the outcome cannot be predicted at this time.

 

The Company has other contingencies that arise in the normal conduct of its operations. In the opinion of management, the resolutions of these contingencies are not expected to have a material impact on the Company’s financial condition or results of operations. However, adverse outcomes are possible and could negatively impact the Company’s financial condition or results of operations.

 

12. Stock Compensation Plans

 

The Company applies the intrinsic value recognition and measurement principles of Accounting Principles Board (APB) Opinion No. 25, Accounting for Stock Issued to Employees, and related interpretations, in accounting for stock based compensation plans. The Company has adopted the disclosure-only provisions of Statement No. 123, Accounting for Stock Based Compensation, as amended.

 

Stock based compensation cost, net of taxes, included in net income under APB Opinion No. 25 was $0.2 million and $0.3 million, respectively, for the second quarter and six months ended June 30, 2003 and $0.1 million and $0.3 million, respectively, for the same periods in 2002. Under the fair value method principles of Statement No. 123, pro forma stock based compensation cost, net of taxes, and pro forma net income would not have differed from reported amounts for the quarter and six month period ended June 30, 2003. Pro forma stock based compensation cost, net of taxes, and pro forma net income would have differed from reported amounts by less than $0.1 million for the quarter and six month period ended June 30, 2002. The pro forma impact of stock options issued after 1994 had no effect on basic or diluted net income per share in the periods presented.

 

14


Table of Contents

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

Critical Accounting Policies

 

The accompanying Consolidated Financial Statements and related notes have been prepared in accordance with U.S. GAAP and include the accounts of Markel Corporation and all subsidiaries (the Company).

 

Critical accounting policies are defined as those that are both important to the portrayal of the Company’s financial condition and results of operations and require management to exercise significant judgment. The preparation of financial statements in accordance with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of material contingent assets and liabilities, including litigation contingencies, at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. These estimates are necessarily based on assumptions about numerous factors.

 

Management reviews its estimates and assumptions quarterly, including the adequacy of reserves for unpaid losses and loss adjustment expenses, reinsurance allowance for doubtful accounts, as well as, the recoverability of deferred tax assets and intangible assets and the evaluation of the investment portfolio for other than temporary declines in value. Actual results may differ materially from the estimates and assumptions used in preparing the consolidated financial statements.

 

Unpaid Losses and Loss Adjustment Expenses

 

The Company accrues liabilities for unpaid losses and loss adjustment expenses based upon estimates of the ultimate amounts payable. As of any balance sheet date, all claims have not yet been reported and some claims may not be reported for many years. As a result, the liability for unpaid losses and loss adjustment expenses includes significant estimates for incurred but not reported claims. Additionally, reported claims are in various stages of the settlement process. Each claim is settled individually based upon its merits and certain claims may take years to settle, especially if legal action is involved.

 

The Company uses a variety of techniques to establish the liabilities for unpaid losses and loss adjustment expenses, all of which involve significant judgments and assumptions. These techniques include detailed statistical analysis of past claim reporting, settlement activity, claim frequency and severity data, internal loss experience, the experience of clients and industry experience. More judgmental techniques are used in lines when statistical data is insufficient or unavailable. Estimates reflect implicit or explicit assumptions regarding the potential effects of external factors that include economic and social inflation, judicial decisions, law changes and recent trends in these factors. In some of the Company’s markets, and where the Company acts as a reinsurer, the timing and amount of information reported about underlying claims is in the control of third parties. This can also affect estimates and cause re-estimation as new information becomes available.

 

Reinsurance recoverables recorded with respect to insurance losses ceded to reinsurers under reinsurance contracts are also subject to estimation error. In addition to the factors cited above, estimates of reinsurance recoverables may prove uncollectible if the reinsurer is unable or unwilling to perform under the contract. The ceding of insurance does not legally discharge the ceding company from its primary liability for the full amount of the policies, and the ceding company is required to pay the loss and bear collection risk if the reinsurer fails to meet its obligation under the reinsurance agreement.

 

15


Table of Contents

The Company’s consolidated balance sheet at June 30, 2003 includes estimated unpaid losses and loss adjustment expenses of $4,467.2 million and reinsurance recoverable on unpaid losses of $1,502.9 million. Due to inherent uncertainties in estimating these amounts, the actual ultimate amounts may differ from the recorded amounts. Future effects from changes in these estimates will be recorded as a component of loss and loss adjustment expenses in the period of the change.

 

Deferred Income Taxes

 

The Company records deferred income taxes as assets or liabilities on its consolidated balance sheet to reflect the net tax effect of the temporary differences between the carrying amounts of the assets and liabilities for financial reporting purposes and their respective tax bases. At June 30, 2003, a net deferred tax asset of $45 million, net of a valuation allowance of $46 million, was recorded. The valuation allowance was established upon the acquisition of Markel International and is considered necessary due to the uncertainty of realizing a future tax benefit on pre-acquisition net operating losses. The Company’s net operating losses (including pre-acquisition losses) are principally attributable to Markel Capital Limited and can be carried forward indefinitely to offset Markel Capital Limited’s future taxable income. In recording this deferred tax asset, management has made estimates and judgments that future taxable income will be sufficient to realize the value of the deferred tax asset.

 

Intangible Assets

 

The Company’s consolidated balance sheet as of June 30, 2003 includes goodwill of acquired businesses of approximately $357 million. This amount has been recorded as a result of prior business acquisitions accounted for under the purchase method of accounting. Under Financial Accounting Standards Board Statement (Statement) No. 142, Goodwill and Other Intangible Assets, goodwill is tested for impairment at least annually in lieu of amortization. The Company has elected September 30 as its annual review date.

 

A significant amount of judgment is required in performing goodwill impairment tests. Such tests include estimating the fair value of the Company’s reporting units. As required by Statement No. 142, the Company compares the estimated fair value of its reporting units with their respective carrying amounts including goodwill. Under Statement No. 142, fair value refers to the amount for which the entire reporting unit may be bought or sold. The Company’s methods for estimating reporting unit values include market quotations, asset and liability fair values and other valuation techniques, such as discounted cash flows and multiples of earnings or revenues. With the exception of market quotations, all of these methods involve significant estimates and assumptions.

 

Investments

 

The Company completes a detailed analysis each quarter to assess whether the decline in the fair value of any investment below cost is deemed other than temporary. All securities with an unrealized loss are reviewed. Unless other factors cause the Company to reach a contrary conclusion, investments with a fair value of less than 80% of cost for more than 180 days are deemed to have a decline in value that is other than temporary. A decline in value that is considered to be other than temporary is charged to earnings based on the fair value of the security at the time of assessment, resulting in a new cost basis for the security.

 

16


Table of Contents

Risks and uncertainties are inherent in the Company’s other than temporary decline in value assessment methodology. Risks and uncertainties could include but are not limited to: incorrect or overly optimistic assumptions about financial condition or liquidity, incorrect or overly optimistic assumptions about future prospects, inadequacy of any underlying collateral, unfavorable changes in economic or social conditions and unfavorable changes in interest rates or credit ratings.

 

Results of Operations

 

Quarter and Six Months ended June 30, 2003 compared to Quarter and Six Months ended June 30, 2002

 

The Company markets and underwrites specialty insurance products and programs to a variety of niche markets. In each of these markets, the Company seeks to be a market leader. The financial goals of the Company are to earn consistent underwriting profits and superior investment returns to build shareholder value.

 

The Company competes in three segments of the specialty insurance marketplace: Excess & Surplus Lines, Specialty Admitted and the London Insurance Market. The Excess and Surplus Lines segment is comprised of five underwriting units, the Specialty Admitted segment consists of two underwriting units and the London Insurance Market segment is comprised of the ongoing operations of Markel International.

 

The Excess and Surplus Lines segment writes property and casualty insurance for non-standard and hard-to-place risks including catastrophe-exposed property, professional liability, products liability, general liability, commercial umbrella and other coverages tailored for unique exposures.

 

The Specialty Admitted segment writes risks that are unique and hard-to-place in the standard market but must remain with an admitted insurance company for marketing and regulatory reasons. The underwriting units in this segment write specialty program insurance for well-defined niche markets and personal and commercial property and liability coverages.

 

The Company participates in the London Insurance Market through Markel Capital Limited and Markel International Insurance Company Limited (MIICL), two wholly-owned subsidiaries. Markel Capital Limited is the corporate capital provider for Markel Syndicate 3000 at Lloyd’s. Markel Syndicate Management Limited, a wholly-owned subsidiary, manages the Company’s Lloyd’s operations. The London Insurance Market segment writes specialty property, casualty, marine and aviation insurance and reinsurance.

 

Discontinued lines of business and non-strategic insurance subsidiaries are included in Other for segment reporting purposes. Other consisted primarily of discontinued Markel International programs and Corifrance, a wholly-owned subsidiary, for the quarters and six month periods ended June 30, 2003 and 2002.

 

The Company is currently experiencing what is commonly referred to within the insurance industry as a hard market, that is stricter coverage terms and higher prices. Submissions and premium writings have increased substantially in the Excess and Surplus Lines and Specialty Admitted Markets since 2000. During 2001, premium rates also began to increase in the London Insurance Market. The terrorist attacks of September 11, 2001 continue to have a profound impact on the insurance market.

 

The Company anticipates that all segments of the specialty insurance marketplace in which it competes will continue to provide a favorable environment for its operations. For 2003 budgeting purposes, the Company anticipates gross premium growth of 15%, with domestic operations slightly higher and international operations

 

17


Table of Contents

slightly lower. Management continues to believe that this is a reasonable growth forecast for the full year. While all of the Company’s insurance operations continue to achieve rate increases compared to the prior year, rate increases have begun to slow in certain lines of business. The Company does not intend to relax underwriting standards in hard or soft insurance markets in order to obtain premium volume. Premium volume may vary significantly if the Company alters its product concentration to maintain or improve underwriting profitability.

 

Following is a comparison of gross premium volume by underwriting segment:

 

Gross Premium Volume

 

Quarter Ended June 30,

        Six Months Ended June 30,

2003

  2002

     

    (dollars in thousands)    


  2003

  2002

$371,802  $304,303     

Excess and Surplus Lines

  $737,411  $585,245
73,700   62,086     

Specialty Admitted

   131,438   108,608
165,888   156,026     

London Insurance Market

   365,578   326,985
7,465   1,300     

Other

   29,164   21,523

  

        

  

$618,855  $523,715     

Total

  $1,263,591  $1,042,361

  

        

  

 

Second quarter gross premium volume rose 18% to $618.9 million from $523.7 million for the same period in 2002. For the six month period of 2003, gross premium volume grew 21% to $1.3 billion from $1.0 billion in the prior year.

 

Excess and Surplus Lines gross premium volume increased 22% to $371.8 million in the second quarter of 2003 from $304.3 million a year ago. For the six month period, gross premium volume increased 26% to $737.4 million in 2003 from $585.2 million in 2002. The growth in both periods was due to increased submission activity and price increases in most programs. The most significant areas of growth in the second quarter of 2003 were in the Investors Brokered Excess and Surplus Lines and the Shand Professional/Products Liability units. Gross premium volume for the Investors Brokered Excess and Surplus Lines unit increased 28% to $102.5 million in the second quarter of 2003 from $79.9 million last year. Shand Professional/Products Liability gross premium volume grew 20% to $104.4 million in the second quarter of 2003 from $87.1 million for 2002. The most significant areas of growth in the six month period of 2003 were in the Investors Brokered Excess and Surplus Lines and Essex Excess and Surplus Lines units. For the six month period of 2003, premium volume for the Investors Brokered Excess and Surplus Lines unit increased 37% to $199.7 million from $145.7 million in the prior year. For the six month period of 2003, premium volume for the Essex Excess and Surplus Lines unit increased 20% to $259.5 million from $216.4 million in the prior year. The increase in gross premium volume at the Investors Brokered Excess and Surplus Lines unit for both periods of 2003 was primarily due to growth in the casualty programs. The increase in gross premium volume at the Shand Professional/Products Liability unit in the second quarter of 2003 was primarily due to growth in the special risk and specified medical programs. The increase in gross premium volume at the Essex Excess and Surplus Lines unit for the six month period was primarily due to growth in the casualty and ocean marine programs.

 

Specialty Admitted Lines gross premium volume in the second quarter of 2003 increased 19% to $73.7 million compared to $62.1 million in 2002. For the six month period, gross premium volume increased 21% to $131.4 million in 2003 from $108.6 million in the prior year. The increase in both periods was primarily due to higher submissions and price increases in most programs.

 

In the second quarter of 2003, gross premium volume for the London Insurance Market segment increased 6%

 

18


Table of Contents

to $165.9 million from $156.0 million in 2002. Gross premium volume for the six months ended June 30, 2003 increased 12% to $365.6 million compared to $327.0 million for the same period of 2002. The growth in both periods of 2003 was primarily due to price increases across most programs. The most significant areas of growth were within the professional indemnity and retail underwriting divisions. The increase in both periods of 2003 continued to meet the Company’s expectations both in terms of volume and price increases achieved.

 

During the second quarter of 2003, A.M. Best (Best) upgraded the financial strength rating of MIICL to “A-” (excellent) from “B++” (very good). The rating action was the result of Best’s view of the strategic importance of MIICL to the Company, improved risk-adjusted capitalization and improved underwriting performance. The upgrade enables the Company to place business on either MIICL or Markel Syndicate 3000, while offering policyholders excellent levels of security. While the rating upgrade is not anticipated to have a significant impact on the total 2003 gross premium volume for the London Insurance Market segment, the Company intends to move premium writings to MIICL where the underwriting, acquisition and insurance expenses are generally a lower percentage of earned premium than in Markel Syndicate 3000.

 

Other gross written premiums consisted primarily of Corifrance’s writings in both periods of 2003 and 2002.

 

The Company purchases reinsurance in order to reduce its retention on individual risks and enable it to write policies with sufficient limits to meet policyholder needs. The Company’s underwriting philosophy seeks to offer products with limits that do not require significant amounts of reinsurance. The Company’s net retention of gross premium volume for the second quarter was 77% in 2003 and 2002. Net retention of gross premium volume for the six month period was 75% in 2003 and 2002.

 

Total operating revenues for the second quarter of 2003 increased to $521.1 million from $400.3 million in the prior year. For the six month period, operating revenues rose to $1,005.1 million from $775.0 million in 2002. The increase in operating revenues for both the second quarter and six month period of 2002 was primarily attributed to higher earned premiums resulting from increasing gross premium volume.

 

Following is a comparison of earned premiums by underwriting segment:

 

Earned Premiums

 

Quarter Ended June 30,

        Six Months Ended June 30,

2003

  2002

     

    (dollars in thousands)    


  2003

  2002

$247,242  $176,659     

Excess and Surplus Lines

  $483,916  $333,787
57,416   43,606     

Specialty Admitted

   112,074   82,767
129,977   119,586     

London Insurance Market

   264,215   242,161
4,238   6,425     

Other

   11,021   15,100

  

        

  

$438,873  $346,276     

Total

  $871,226  $673,815

  

        

  

 

Earned premiums for the second quarter of 2003 increased 27% to $438.9 million from $346.3 million for the same period in 2002. For the six month period, earned premiums grew 29% to $871.2 million in 2003 from $673.8 in the prior year.

 

Excess and Surplus Lines earned premiums for the second quarter of 2003 increased 40% to $247.2 million from $176.7 million for the same period in 2002. For the six month period, Excess and Surplus Lines earned premiums grew 45% to $483.9 million in 2003 from $333.8 million in the prior year. The growth in both periods of 2003 was primarily due to higher gross premium volume and higher retentions over the past year in all Excess and Surplus Lines units.

 

19


Table of Contents

Earned premiums for the Specialty Admitted segment increased 32% to $57.4 million in the second quarter of 2003 from $43.6 million for the same period in 2002. For the six month period, Specialty Admitted earned premiums grew 35% to $112.1 million in 2003 from $82.8 million in the prior year. The increase in 2003 for both periods was primarily due to growth in new programs and higher gross premium volume in existing lines of business over the past year.

 

London Insurance Market earned premiums increased 9% for the quarter and six month period ended June 30, 2003 from the same periods in 2002. Earned premiums for London Insurance Market were $130.0 million for the second quarter of 2003 up from $119.6 million for the same period in 2002. For the six month period, London Insurance Market earned premiums grew to $264.2 million in 2003 from $242.2 million in the prior year. The growth in 2003 was primarily the result of increased gross premium volume over the past several quarters and higher retentions across most of the underwriting divisions in the London Insurance Market segment.

 

Other earned premiums decreased in 2003 due to the run off of discontinued programs. Other earned premiums consists primarily of business written by Corifrance in all periods presented.

 

Second quarter 2003 net investment income was $45.5 million compared to $42.6 million in the prior year. Net investment income for the six month period ended June 30, 2003 was $90.7 million compared to $84.0 million in 2002. In both periods, a larger investment portfolio offset lower investment yields.

 

In the second quarter of 2003, the Company recognized $36.7 million of net realized gains compared to $11.5 million of net realized gains in 2002. For the six month period of 2003, net realized gains were $43.2 million compared to net realized gains of $17.1 million for the same period last year. Realized gains in both periods of 2003 were primarily the result of the Company’s decision to sell certain government securities and buy higher yielding fixed income investments, including tax-exempt municipal bonds. Variability in the timing of realized and unrealized investment gains and losses is to be expected.

 

Net realized gains in the second quarter of 2003 were partially offset by $3.5 million of realized losses resulting from the write down of a fixed income security. For the six months ended June 30, 2003, net realized gains were partially offset by $15.0 million of realized losses resulting from the write down of one fixed income security and five equity securities to their estimated fair value. These securities were deemed by management to have a decline in value that was other than temporary. For the quarter and six months ended June 30, 2002, management determined there were no securities with a decline in value that was other than temporary. At June 30, 2003, the Company held securities with gross unrealized losses of approximately $9 million, or significantly less than 1% of the Company’s total investments, cash and cash equivalents. At June 30, 2003, all of these securities were reviewed and the Company believes there were no indications of impairment.

 

Total operating expenses for the second quarter of 2003 were $419.6 million compared to $353.6 million in 2002. Total operating expenses for the six month period of 2003 were $837.9 million compared to $692.1 million a year ago. The increase in both periods of 2003 was primarily the result of higher loss and loss adjustment expenses and higher underwriting, acquisition and insurance expenses as a result of higher premium volume compared to the same periods of 2002.

 

20


Table of Contents

Following is a comparison of selected data from the Company’s operations (dollars in thousands):

 

   Quarter Ended
June 30,


  Six Months Ended
June 30,


   2003

  2002

  2003

  2002

Gross premium volume

  $618,855  $523,715  $1,263,591  $1,042,361

Net premiums written

   475,871   403,172   950,834   777,288

Net retention

   77%   77%   75%   75%

Earned premiums

   438,873   346,276   871,226   673,815

Losses and loss adjustment expenses

   279,933   239,268   559,952   473,724

Underwriting, acquisition and insurance expenses

   138,157   111,669   273,793   212,918
   

  

  

  

U.S. GAAP Combined Ratios

                

Excess and Surplus Lines

   88%   93%   88%   94%

Specialty Admitted

   92%   105%   95%   102%

London Insurance Market

   102%   107%   102%   109%

Other

   342%   186%   269%   162%

Markel Corporation (Consolidated)

   95%   101%   96%   102%
   

  

  

  

 

The U.S. GAAP combined ratio measures the relationship of incurred losses, loss adjustment expenses and underwriting, acquisition and insurance expenses to earned premiums. A combined ratio of less than 100% indicates an underwriting profit, while a combined ratio greater than 100% reflects an underwriting loss. See note 7 of the notes to consolidated financial statements for further discussion of segment underwriting profit (loss).

 

The Company reported a combined ratio of 95% in the second quarter of 2003 compared to a combined ratio of 101% in the second quarter of 2002. For the six month period of 2003, the Company reported a combined ratio of 96% compared to 102% for the same period of 2002.

 

The combined ratio for Excess and Surplus Lines decreased to 88% for the second quarter and six month period of 2003 from 93% and 94%, respectively, for the same periods of 2002. The improvement for both periods of 2003 resulted primarily from favorable development of prior years’ loss reserves in the Essex E&S Lines and the Shand Professional/Products Liability units and lower current year loss ratios on Investors Brokered Excess and Surplus Lines. This favorable development was partially offset by adverse development of prior years’ loss reserves in the Investors Brokered Excess and Surplus Lines unit. During the six months ended June 30, 2003, this unit experienced approximately $11 million of adverse development on loss reserves primarily for business written between 1996 and 2000. The Excess and Surplus Lines segment continues to benefit from improved pricing, more restrictive coverage and better risk selection.

 

The combined ratio for Specialty Admitted was 92% and 95%, respectively, for the second quarter and six month period of 2003 compared to combined ratios of 105% and 102%, respectively, for the same periods of 2002. The improvement in both periods of 2003 was primarily the result of favorable development on prior years’ loss reserves. The Company continues to focus on pricing, risk selection and expense control to meet its profitability goals for the Specialty Admitted segment.

 

The combined ratio for the London Insurance Market segment improved to 102% for the quarter and six months ended June 30, 2003 compared to 107% and 109%, respectively, for the same periods of 2002. The improvement in both periods of 2003 has resulted from a combination of lower loss ratios due to improved risk selection, pricing and the appropriate use of reinsurance and lower expense ratios due to lower commissions and

 

21


Table of Contents

expense control. The London Insurance Market segment combined ratio has steadily improved and the London underwriting units continue to work towards their goal of underwriting profitability.

 

The underwriting loss from Other, which includes discontinued lines of business, was $10.3 million and $18.6 million, respectively, for the second quarter and six month period ended June 30, 2003 compared to $5.5 million and $9.4 million, respectively, in the same periods of 2002. The increase in the underwriting loss for both periods was primarily due to increases in the allowance for potentially uncollectible reinsurance and run off provisions for discontinued lines of business.

 

Amortization of intangible assets was $1.5 million in the second quarter of 2003 compared to $2.6 million last year. For the six month period of 2003, amortization of intangible assets was $4.1 million compared to $5.4 million for the same period of 2002. Intangible assets, other than goodwill, were fully amortized at the end of the second quarter of 2003.

 

Interest expense was $13.6 million for the second quarter of 2003 compared to $10.9 million for the same period of 2002. For the six months ended June 30, 2003, interest expense was $25.0 million compared to $20.0 million for the same period last year. The increase in both periods is primarily due to the Company’s 2003 issuance of $250 million of 6.80% unsecured senior notes, due February 15, 2013. A portion of the net proceeds was used to repay $175 million outstanding under the Company’s revolving credit facility.

 

For the second quarter and six months ended June 30, 2003, the Company’s effective tax rate was 33% compared to 35% and 36%, respectively, for the second quarter and six month period of 2002. The decrease was primarily due to the elimination during 2002 of non-deductible interest expense as a result of the exchange of previously issued 7.0% and 7.2% senior notes of Markel International Limited, a wholly-owned subsidiary, for newly issued 7.0% and 7.2% senior notes of the Company. During 2003, the Company also increased investment allocations to tax exempt municipal securities.

 

Comprehensive income was $151.2 million for the second quarter of 2003 compared to $37.7 million for the same period of 2002. For the six month period ended June 30, 2003, comprehensive income was $169.9 million compared to $42.0 million in 2002. The improvement in both periods of 2003 was primarily due to a significant increase in the market value of the Company’s investment portfolio during the second quarter of 2003 and significantly higher net income compared to 2002. Comprehensive income for the second quarter of 2003 includes a $4.7 million gain from currency translation adjustments, net of taxes, compared to a gain of $3.8 million for the same period of 2002. For the six month period of 2003, gains from currency translation adjustments, net of taxes, were $6.7 million compared to gains of $3.3 million for the same period of 2002. The Company attempts to match assets and liabilities in original currencies to mitigate the impact of currency volatility.

 

Financial Condition as of June 30, 2003

 

At June 30, 2003, the Company’s investment portfolio increased 12% to $4,820.6 million from $4,314.2 million at December 31, 2002. The Company reported net unrealized gains, net of taxes, on its fixed maturity and equity investments of $247.0 million at June 30, 2003 compared to $179.2 million at December 31, 2002. Equity securities were $729.2 million, or 15% of the total investment portfolio, at June 30, 2003 compared to $550.9 million, or 13%, at December 31, 2002.

 

22


Table of Contents

For the six month period ended June 30, 2003, the Company reported net cash provided by operating activities of $258.5 million, compared to $150.0 million for the same period in 2002. The increase in cash provided by operations was primarily due to increased cash flows in the Excess and Surplus Lines segment due to growth in gross premium volume and continued underwriting profitability. In addition, as the underwriting loss in the London Insurance Market segment has declined operating cash flows have improved.

 

For the six month period ended June 30, 2003, the Company reported net cash used by investing activities of $426.0 million compared to $19.1 million in 2002. The increased use of cash for investing activities during 2003 was primarily due to the allocation of increased operating cash flows to the Company’s investment portfolio.

 

For the six month period ended June 30, 2003, the Company reported net cash provided by financing activities of $72.6 million compared to net cash used by financing activities of $2.7 million in 2002. The net cash provided by financing activities during the six month period ended June 30, 2003 was primarily the result of the debt issuances during the first and second quarters of 2003 partially offset by the repayment of the outstanding balance under the Company’s revolving credit facility.

 

During the second quarter, the Company contributed approximately $49 million of capital to Markel Capital Limited to support insurance operations at Markel Syndicate 3000. Subsequent to June 30, 2003, the Company contributed an additional $45 million of capital to MIICL to support premium writings.

 

Before the end of the year, capital providers at Lloyd’s are required to post collateral to support their premium writings for the next year. During the fourth quarter of 2003, the Company anticipates contributing up to $75 million of additional capital to Markel Capital Limited to support Markel Syndicate 3000 premium writings for 2004. The Company’s domestic insurance operations may also require capital to support 2004 premium writings. The Company also has $67 million of notes that mature on November 1, 2003. The Company has access to various capital sources including holding company investments and cash, $300 million of undrawn capacity under its revolving credit facility and access to the debt and equity capital markets. The Company has an existing shelf registration statement under which up to $180 million of equity or debt securities may be issued. Management believes the Company has sufficient liquidity to meet its capital needs.

 

Shareholders’ equity at June 30, 2003 was $1,329.3 million compared to $1,159.1 million at December 31, 2002. Book value per common share was $135.07 at June 30, 2003, compared to $117.89 at December 31, 2002. The 2003 increase was primarily the result of $95.3 million of net income and a $67.8 million increase in net unrealized investment gains, net of taxes, during the six months ended June 30, 2003.

 

Item 3. Quantitative and Qualitative Disclosures About Market Risk

 

Market risk is the risk of economic losses due to adverse changes in the estimated fair value of a financial instrument as the result of changes in equity prices, interest rates, foreign exchange rates and commodity prices. The Company’s consolidated balance sheets include assets and liabilities whose estimated fair values are subject to market risk. The primary market risks to the Company are equity price risk associated with investments in equity securities, interest rate risk associated with investments in fixed maturities and foreign exchange risk at Markel International. The Company has no material commodity risk.

 

The Company primarily manages foreign exchange risk by matching assets and liabilities in each foreign

 

23


Table of Contents

currency as closely as possible. Significant estimations and assumptions are required when establishing insurance balances such as reinsurance recoverables and reserves for unpaid losses and loss adjustment expenses. As a result, matching of assets and liabilities by currency is subject to change as actual results emerge.

 

The Company’s market risks at June 30, 2003 have not materially changed from those identified at December 31, 2002.

 

Item 4. Controls and Procedures

 

As of the end of the period covered by this quarterly report, the Company carried out an evaluation, under the supervision and with the participation of the Company’s management, including the Chairman and Chief Executive Officer (CEO) and the Executive Vice President and Chief Financial Officer (CFO), of the effectiveness of the design and operation of the Company’s disclosure controls and procedures pursuant to Securities Exchange Act Rule 13a-15 (Disclosure Controls).

 

The Company’s management, including the CEO and CFO, does not expect that its Disclosure Controls will prevent all error and all fraud. A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Further, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within the Company have been detected. These inherent limitations include the realities that judgments in decision-making can be faulty, and that breakdowns can occur because of simple error or mistake. The design of any system of controls also is based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions.

 

Based upon the Company’s controls evaluation, the CEO and CFO have concluded that the Company’s Disclosure Controls provide reasonable assurance that the information required to be disclosed by the Company in its periodic reports is accumulated and communicated to management, including the CEO and CFO, as appropriate to allow timely decisions regarding disclosure and is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms.

 

There have been no changes in the Company’s internal control over financial reporting during the Company’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting.

 

24


Table of Contents

Safe Harbor and Cautionary Statement

 

This is a “Safe Harbor” statement under the Private Securities Litigation Reform Act of 1995. It also contains general cautionary statements regarding the Company’s business, estimates and management assumptions. Future actual results may materially differ from those described in this report because of many factors. Among other things,

 

 The impact of the events of September 11, 2001 will depend on the number of insureds and reinsureds affected by the events, the amount and timing of losses incurred and reported and questions of how coverage applies;

 

 The occurrence of additional terrorist activities could have a material impact on the Company and the insurance industry;

 

 The Company’s anticipated premium growth and anticipated improvements in underwriting profitability are based on current knowledge and assume no significant man-made or natural catastrophes, no significant changes in products or personnel and no adverse changes in market conditions;

 

 The Company is legally required to offer terrorism insurance and has attempted to manage its exposure. However, in the event of a covered terrorist attack, the Company could sustain material losses;

 

 Changing legal and social trends and inherent uncertainties in the loss estimation process can adversely impact the adequacy of loss reserves and the allowance for reinsurance recoverables;

 

 Industry and economic conditions can affect the ability and/or willingness of reinsurers to pay balances due;

 

 The Company continues to closely monitor discontinued lines and reinsurance programs and exposures. Adverse experience in these areas could lead to additional charges;

 

 Regulatory actions can impede the Company’s ability to charge adequate rates and efficiently allocate capital; and

 

 Economic conditions, interest rates and foreign exchange rate volatility can have a significant impact on the market value of fixed maturity and equity investments as well as the carrying value of other assets and liabilities.

 

The Company’s premium growth, underwriting and investment results have been and will continue to be potentially materially affected by these factors. Additional factors, which could affect the Company, are discussed in the Company’s reports on Forms 8-K, 10-Q and 10-K. By making these forward looking statements, the Company is not intending to become obligated to publicly update or revise any forward looking statements whether as a result of new information, future events or other changes. Readers are cautioned not to place undue reliance on any forward looking statements, which speak only as at their dates.

 

PART II. OTHER INFORMATION

 

Item 4. Submission of Matters to a Vote of Security Holders

 

The Company’s Annual Meeting was held on May 14, 2003, in Richmond, Virginia. At the Annual Meeting, shareholders elected directors for the ensuing year, ratified the selection by the Board of Directors of KPMG LLP as the Company’s independent auditors for the year ending December 31, 2003, approved the Company’s Omnibus Incentive Plan and approved an amendment to the Company’s Bylaws to change the

 

25


Table of Contents

number of directors to not less than three nor more than fifteen. The results of the meeting were as follows:

 

Election of Directors


  For

  Withheld

Alan I. Kirshner

  7,880,250  920,917

Anthony F. Markel

  7,838,088  963,079

Steven A. Markel

  7,883,867  917,300

Darrell D. Martin

  7,887,550  913,617

Douglas E. Eby

  8,546,940  254,227

Thomas S. Gayner

  7,881,221  919,946

Leslie A. Grandis

  7,528,162  1,273,005

Stewart M. Kasen

  8,491,351  309,816

Gary L. Markel

Jay M. Weinberg

  

7,571,560

8,508,928

  

1,229,607

292,239

 

Ratification of Selection of Auditors:

 

For


  

Against


  

Abstentions and Brokers
Non-Votes


8,535,523

  258,686  6,958

 

Approval of Omnibus Incentive Plan:

 

For


  

Against


  

Abstentions and Brokers
Non-Votes


7,984,409

  685,365  131,393

 

Approval of Bylaw Amendment:

 

For


  

Against


  

Abstentions and Brokers
Non-Votes


8,573,460

  116,174  111,533

 

Item 6. Exhibits and Reports on Form 8-K

 

(a) Exhibits.

 

The Exhibits to this Report are listed in the Exhibit Index.

 

(b)(1) On April 9, 2003, the Company filed a report on form 8-K reporting under Item 5 and Item 7 related to the issuance of $50 million principal amount of 6.8% Senior Notes due 2013.
(b)(2) On April 30, 2003, the Company filed a report on Form 8-K furnishing under Item 7 and Item 9 (Item 12) a copy of the Company’s press release announcing first quarter 2003 financial results.

 

26


Table of Contents

Signatures

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized, this 6th day of August, 2003.

 

The Company

By

 

/s/ Alan I. Kirshner


  

Alan I. Kirshner

  

Chairman and Chief Executive Officer

(Principal Executive Officer)

By

 

/s/ Anthony F. Markel


  

Anthony F. Markel

  

President

  

(Principal Operating Officer)

By

 

/s/ Steven A. Markel


  

Steven A. Markel

  

Vice Chairman

By

 

/s/ Darrell D. Martin


  

Darrell D. Martin

  

Executive Vice President and

Chief Financial Officer

  

(Principal Financial Officer and

Principal Accounting Officer)

 

27


Table of Contents

Exhibit Index

 

Number


  

Description


3(i)  Amended and Restated Articles of Incorporation, as amended (3.1)a
3(ii)  Bylaws, as amended (4.2)b
4(i)  Credit Agreement dated December 21, 1999, among Markel Corporation, the lenders named therein and First Union National Bank, as Agent (4(i))c
4(ii)  First Amendment dated February 4, 2000, to Credit Agreement dated December 21, 1999 among Markel Corporation, the lenders named therein and First Union National Bank, as Agent (4(ii))c
4(iii)  Second Amendment and Consent dated March 17, 2000, to Credit Agreement dated December 21, 1999 among Markel Corporation, the lenders named therein and First Union National Bank, as Agent (4(iii))c
4(iv)  Third Amendment dated August 2, 2000, to Credit Agreement dated December 21, 1999 among Markel Corporation, the lenders named therein and First Union National Bank, as Agent (4(iv))c
4(v)  Fourth Amendment dated March 23, 2001, to Credit Agreement dated December 21, 1999 among Markel Corporation, the lenders named therein and First Union National Bank, as Agent (4(v))c
4(vi)  Fifth Amendment dated June 6, 2003, to Credit Agreement dated December 21, 1999 among Markel Corporation, the lenders named therein and Wachovia Bank, National Association (formerly known as First Union National Bank), as Agent
   The registrant hereby agrees to furnish to the Securities and Exchange Commission a copy of all instruments defining the rights of holders of convertible notes payable and long-term debt of the registrant and subsidiaries shown on the Consolidated Balance Sheet of the registrant at June 30, 2003 and the respective Notes thereto, included in the Quarterly Report on Form 10-Q.
10.1  Markel Corporation Omnibus Incentive Plan d
10.2  Executive Employment Agreement between Markel Corporation and Thomas S. Gayner dated as of June 1, 2003
10.3  2003 Incentive Compensation Arrangement for Thomas S. Gayner
10.4  Restricted Stock Unit Award for Thomas S. Gayner
10.5  Executive Employment Agreement between Markel Corporation and Paul W. Springman dated as of June 1, 2003
10.6  2003 Incentive Compensation Arrangement for Paul W. Springman
10.7  Restricted Stock Unit Award for Paul W. Springman
10.8  Form of Restricted Stock Unit Award for Directors
31.1  Certification of Principal Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
31.2  Certification of Principal Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
32.1  Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
32.2  Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

a. 

Incorporated by reference from the exhibit shown in parentheses filed with the Commission in the

 

28


Table of Contents
 

Registrant’s report on Form 10-Q for the quarter ended March 31, 2000.

 

b. Incorporated by reference from Exhibit 4.2 to S-8 Registration Statement No. 333-107661, dated August 5, 2003.

 

c. Incorporated by reference from the exhibit shown in parentheses filed with the Commission in the Registrant’s report on Form 10-Q for the quarter ended September 30, 2002.

 

d. Incorporated by reference from Appendix B to the Registrant’s Proxy Statement for the Annual Meeting of Shareholders held on May 14, 2003.

 

29